Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process

被引:14
作者
Zheng, JL [1 ]
Zhang, PJ [1 ]
Hexum, TD [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA
关键词
D O I
10.1124/mol.52.6.1027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Acetylcholine stimulation of bovine chromaffin cells results in increased norepinephrine and epinephrine secretion accompanied by a corresponding increase in synthesis. The addition of neuropeptide Y (NPY) to the culture medium prevents the increase in catecholamine synthesis but not secretion. Treatment of chromaffin cells with nicotine produces a concentration-dependent increase in tyrosine hydroxylase activity (IC50 = 1.2 mu M) that is reduced if NPY is present during stimulation. Tyrosine hydroxylase activity decreases in a concentration-dependent fashion if increasing amounts of NPY are included in the culture medium, IC50 = 0.2 nM. Treatment with pertussis toxin completely prevents the effect of NPY. The rank order of potency for inhibition of tyrosine hydroxylase activity is NPY greater than or equal to [Leu(31),Pro(34)]NPY greater than or equal to peptide YY > NPY2-36 > NPY13-36 > NPY18-36 greater than or equal to NPY26-36 much greater than NPY1-30, suggesting a NPY-Y1 receptor subtype. Examination of the effect of NPY on nicotine stimulation of chromaffin cell protein phosphorylation showed that NPY produces a concentration-dependent decrease in a 60-kDa protein, IC50 = 6.4 nM. The effect of NPY is pertussis toxin-sensitive. The rank order of potency is [Leu(31),Pro(34)]NPY greater than or equal to NPY much greater than NPY18-36. Immunoprecipitation confirmed the identity of the 60-kDa protein as tyrosine hydroxylase.
引用
收藏
页码:1027 / 1033
页数:7
相关论文
共 40 条
[1]   CHOLINOCEPTOR REGULATION OF CYCLIC-AMP LEVELS IN BOVINE ADRENAL-MEDULLARY CELLS [J].
ANDERSON, K ;
ROBINSON, PJ ;
MARLEY, PD .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (02) :360-366
[2]   CLONING AND FUNCTIONAL EXPRESSION OF A HUMAN Y4 SUBTYPE RECEPTOR FOR PANCREATIC-POLYPEPTIDE, NEUROPEPTIDE-Y, AND PEPTIDE YY [J].
BARD, JA ;
WALKER, MW ;
BRANCHEK, TA ;
WEINSHANK, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) :26762-26765
[3]   INVOLVEMENT OF G-PROTEIN ALPHA-I1 SUBUNITS IN ACTIVATION OF G-PROTEIN GATED INWARD RECTIFYING K+ CHANNELS (GIRK1) BY HUMAN NPY1 RECEPTORS [J].
BROWN, NA ;
MCALLISTER, G ;
WEINBERG, D ;
MILLIGAN, G ;
SEABROOK, GR .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (05) :2346-2348
[4]   INHIBITORY EFFECT OF NEUROPEPTIDE-Y (NPY) ON THE IN-VITRO ACTIVITY OF TYROSINE-HYDROXYLASE [J].
CHENG, JT ;
CHANG, CL ;
TSAI, CL .
NEUROSCIENCE LETTERS, 1994, 167 (1-2) :117-120
[5]   ATP serves as a negative feedback inhibitor of voltage-gated Ca2+ channel currents in cultured bovine adrenal chromaffin cells [J].
Currie, KPM ;
Fox, AP .
NEURON, 1996, 16 (05) :1027-1036
[6]   MOLECULAR-CLONING OF A NOVEL-G PROTEIN-COUPLED RECEPTOR THAT MAY BELONG TO THE NEUROPEPTIDE RECEPTOR FAMILY [J].
EVA, C ;
KEINANEN, K ;
MONYER, H ;
SEEBURG, P ;
SPRENGEL, R .
FEBS LETTERS, 1990, 271 (1-2) :81-84
[7]   EXPRESSION CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF A HUMAN HIPPOCAMPAL NEUROPEPTIDE-Y PEPTIDE YY Y2 RECEPTOR SUBTYPE [J].
GERALD, C ;
WALKER, MW ;
VAYSSE, PJJ ;
HE, CG ;
BRANCHEK, TA ;
WEINSHANK, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) :26758-26761
[8]   A receptor subtype involved in neuropeptide-Y-induced food intake [J].
Gerald, C ;
Walker, MW ;
Criscione, L ;
Gustafson, EL ;
BatzlHartmann, C ;
Smith, KE ;
Vaysse, P ;
Durkin, MM ;
Laz, TM ;
Linemeyer, DL ;
Schaffhauser, AO ;
Whitebread, S ;
Hofbauer, KG ;
Taber, RI ;
Branchek, TA ;
Weinshank, RL .
NATURE, 1996, 382 (6587) :168-171
[9]  
GOLDSTEIN M, 1995, J NEUROCHEM, V64, P2281
[10]  
GRUNDEMAR L, 1997, NEUROPEPTIDE Y DRUG, P1